EX-16.1 2 ex_103149.htm EXHIBIT 16.1 ex_103149.htm

Exhibit 16.1

 

 

January 16, 2018

 

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington DC 20549

 

Re: CEN Biotech, Inc.

 

Ladies and Gentlemen:

 

We have read CEN Biotech, Inc.’s Form 8-K dated January 16, 2018, and are in agreement with the statements in Item 4.01 contained therein, as they relate to our firm.

 

Very truly yours,

 

/S/ Thayer O’Neal Company, LLC

 

Thayer O’Neal Company, LLC

 

Houston, Texas